Effect of high-dose fluconazole on QT interval in patients with human immunodeficiency virus (HIV)-associated cryptococcal meningitis

Effect of high-dose fluconazole on QT interval in patients with human immunodeficiency virus (HIV)-associated cryptococcal meningitis

Saved in:

Bibliographic Details
Main Authors:	Weerawat Manosuthi, Somnuek Sungkanuparph, Thanomsak Anekthananon, Khuanchai Supparatpinyo, Tracy L. Nolen, Louise O. Zimmer, Peter G. Pappas, Robert A. Larsen, Scott G. Filler, Ploenchan Chetchotisakd
Format:	Journal
Published:	2018
Subjects:	Medicine
Online Access:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=70149125189&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/49290
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	Chiang Mai University

Similar Items

Effect of high-dose fluconazole on QT interval in patients with human immunodeficiency virus (HIV)-associated cryptococcal meningitis
by: Weerawat Manosuthi, et al.
Published: (2018)

Effect of high-dose fluconazole on QT interval in patients with human immunodeficiency virus (HIV)-associated cryptococcal meningitis
by: Weerawat Manosuthi, et al.
Published: (2018)

Effect of high-dose fluconazole on QT interval in patients with human immunodeficiency virus (HIV)-associated cryptococcal meningitis
by: Manosuthi W., et al.
Published: (2014)

Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV-associated cryptococcal meningitis-infected patients
by: Manosuthi W., et al.
Published: (2017)

A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis
by: Peter G. Pappas, et al.
Published: (2018)

A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis
by: Peter G. Pappas, et al.
Published: (2018)

A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis
by: Peter G. Pappas, et al.
Published: (2018)

Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV-associated cryptococcal meningitis-infected patients
by: W. Manosuthi, et al.
Published: (2018)

Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV-associated cryptococcal meningitis-infected patients
by: W. Manosuthi, et al.
Published: (2018)

Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: A prospective multicenter study
by: Somnuek Sungkanuparph, et al.
Published: (2018)

Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: A prospective multicenter study
by: Somnuek Sungkanuparph, et al.
Published: (2018)

Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: A prospective multicenter study
by: Somnuek Sungkanuparph, et al.
Published: (2018)

A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis
by: Pappas P.G., et al.
Published: (2014)

Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patients
by: T. Anekthananon, et al.
Published: (2018)

Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patients
by: T. Anekthananon, et al.
Published: (2018)

Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patients
by: Anekthananon T., et al.
Published: (2014)

Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: A prospective multicenter study
by: Sungkanuparph S., et al.
Published: (2014)

Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis
by: Weerawat Manosuthi, et al.
Published: (2018)

Mortality rate of early versus deferred initiation of antiretroviral therapy in HIV-1-infected patients with cryptococcal meningitis
by: Weerawat Manosuthi, et al.
Published: (2018)

Temporary external lumbar drainage for reducing elevated intracranial pressure in HIV-infected patients with cryptococcal meningitis
by: Weerawat Manosuthi, et al.
Published: (2018)

Safety and tolerability of nevirapine-based antiretroviral therapy in HIV-infected patients receiving fluconazole for cryptococcal prophylaxis: A case-control study
by: Weerawat Manosuthi, et al.
Published: (2018)

Efficacy and safety of fluconazole conbined with amphotericin B for treatment of cryptococcal meningitis in patients with AIDS
by: Chankig Puttilerpong, 1975-
Published: (2007)

An open label randomized controlled trial of tamoxifen combined with amphotericin B and Fluconazole for cryptococcal meningitis
by: Nguyen Thi Thuy Ngan, et al.
Published: (2022)

Survival time of HIV-infected patients with cryptococcal meningitis
by: Suthat Chottanapund, et al.
Published: (2018)

Timing of cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in patients with AIDS and cryptococcal meningitis [1]
by: Somnuek Sungkanuparph, et al.
Published: (2018)

A multicentre, randomized, double-blind, placebo-controlled trial of primary cryptococcal meningitis prophylaxis in HIV-infected patients with severe immune deficiency
by: Ploenchan Chetchotisakd, et al.
Published: (2018)

Evaluation of latex cryptococcal agglutination test in cryptococcal meningitis.
by: S. Niemhom, et al.
Published: (2018)

Comparison of one week with two week regimens of amphotericin B both followed by fluconazole in the treatment of cryptococcal meningitis among AIDS patients
by: Somsit Tansuphaswadikul, et al.
Published: (2018)

Cryptococcal meningitis in human immunodeficiency virus (HIV)-positive and HIV-negative patients.
by: P. Viriyavejakul, et al.
Published: (2018)

Combination antifungal therapies for HIV-associated cryptococcal meningitis: A randomised trial
by: Annemarie E. Brouwer, et al.
Published: (2018)

Oral versus intravenous flucytosine in patients with human immunodeficiency virus-associated cryptococcal meningitis
by: Annemarie E. Brouwer, et al.
Published: (2018)

Anti-GM-CSF autoantibodies in patients with cryptococcal meningitis
by: Lindsey B. Rosen, et al.
Published: (2018)

Survival time of HIV-infected patients with cryptococcal meningitis
by: Suthat Chottanapund
Published: (2023)

In vitro-clinical correlations for amphotericin B susceptibility in AIDS-associated cryptococcal meningitis
by: R. A. Larsen, et al.
Published: (2018)

Plasma nevirapine levels, adverse events and efficacy of antiretroviral therapy among HIV-infected patients concurrently receiving nevirapine-based antiretroviral therapy and fluconazole
by: Weerawat Manosuthi, et al.
Published: (2018)

Peripheral Eosinophilia in the Course of Treatment of Cryptococcal Meningitis. Periphere Eosinophilic während der Therapie einer Cryptococcus‐Meningitis
by: E. Schmutzhard, et al.
Published: (2018)

Concomitant tuberculous and cryptococcal thyroid abscess in a human immunodeficiency virus-infected patient
by: Sasisopin Kiertiburanakul, et al.
Published: (2018)

Do intracerebral cytokine responses explain the harmful effects of dexamethasone in human immunodeficiency virus–associated cryptococcal meningitis?
by: Justin Beardsley, et al.
Published: (2020)

IFN-γ at the site of infection determines rate of clearance of infection in cryptococcal meningitis
by: Asna A. Siddiqui, et al.
Published: (2018)

Cerebrospinal fluid HIV-1 viral load during treatment of cryptococcal meningitis
by: Annemarie E. Brouwer, et al.
Published: (2018)